# Dermata Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jan 8, 2026

- Company: [Dermata Therapeutics, Inc.](/companies/drma.md) (CIK 1853816)
- Form: SCHEDULE 13D/A
- Filed: 2026-01-08
- Accepted by EDGAR: Jan 8, 2026, 16:05 ET
- Period: not reported
- Accession: 0001493152-26-000967
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1853816/000149315226000967/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1853816/000149315226000967/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1853816/000149315226000967/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-000967. Last ingested by Listed: Nov 11, 2026, 00:26 ET. No prices; not investment advice.
